TMBR
Timber Pharmaceuticals, Inc.
TMBR
TMBR
Delisted
TMBR was delisted on the 28th of November, 2023.
15 hedge funds and large institutions have $1.04M invested in Timber Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$91.8K | |
| 2 | +$21K | |
| 3 | +$19K | |
| 4 |
BlackRock
New York
|
+$14.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$4K |
Top Sellers
| 1 | -$66K | |
| 2 | -$32.9K | |
| 3 | -$21K | |
| 4 |
Two Sigma Advisers
New York
|
-$17K |
| 5 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$5K |